Baldwin Wealth Partners’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Baldwin Wealth Partners’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,500	Closed	-$12K	–	823
2022 Q3	$12K	Hold	2,500	–	–	﹤0.01%	500
2022 Q2	$10K	Hold	2,500	–	–	﹤0.01%	534
2022 Q1	$15K	Hold	2,500	–	–	﹤0.01%	506
2021 Q4	$19K	Hold	2,500	–	–	﹤0.01%	455
2021 Q3	$23K	Hold	2,500	–	–	﹤0.01%	444
2021 Q2	$30K	Hold	2,500	–	–	﹤0.01%	421
2021 Q1	$31K	Hold	2,500	–	–	﹤0.01%	401
2020 Q4	$39K	Hold	2,500	–	–	﹤0.01%	346
2020 Q3	$24K	Hold	2,500	–	–	﹤0.01%	370
2020 Q2	$22K	Hold	2,500	–	–	﹤0.01%	382
2020 Q1	$16K	Hold	2,500	–	–	﹤0.01%	392
2019 Q4	$21K	Buy	2,500 +1,000	+67%	+$9.2K	﹤0.01%	404
2019 Q3	$14K	Hold	1,500	–	–	﹤0.01%	429
2019 Q2	$16K	Hold	1,500	–	–	﹤0.01%	416
2019 Q1	$14K	Hold	1,500	–	–	﹤0.01%	427
2018 Q4	$17K	Hold	1,500	–	–	﹤0.01%	396
2018 Q3	$25K	Hold	1,500	–	–	﹤0.01%	386
2018 Q2	$21K	Hold	1,500	–	–	﹤0.01%	398
2018 Q1	$29K	Hold	1,500	–	–	﹤0.01%	350
2017 Q4	$25K	Hold	1,500	–	–	﹤0.01%	351
2017 Q3	$23K	Hold	1,500	–	–	﹤0.01%	352
2017 Q2	$13K	Hold	1,500	–	–	﹤0.01%	412
2017 Q1	$8K	Hold	1,500	–	–	﹤0.01%	432
2016 Q4	$5K	Hold	1,500	–	–	﹤0.01%	472
2016 Q3	$7K	Hold	1,500	–	–	﹤0.01%	476
2016 Q2	$9K	Hold	1,500	–	–	﹤0.01%	405
2016 Q1	$9K	Buy	+1,500	New	+$9.01K	﹤0.01%	422

Other funds holding SGMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baldwin Wealth Partners's SGMO Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2022, closing a stake of 2,500 shares — an estimated $12K sold.

Baldwin Wealth Partners first reported a position in SGMO in Q1 2016 and held it in 27 quarters. The position peaked at $39K in Q4 2020. 182 funds tracked by Wall St. Rank hold SGMO as of Q4 2022.

Baldwin Wealth Partners reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2022 after selling out during the quarter.
Baldwin Wealth Partners sold 2,500 SANGAMO THERAPEUTICS INC shares in Q4 2022, an estimated $12K.
Baldwin Wealth Partners first reported a position in SANGAMO THERAPEUTICS INC in Q1 2016 and held it in 27 quarters.
Baldwin Wealth Partners's SANGAMO THERAPEUTICS INC position peaked at $39K in Q4 2020.
182 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.